Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013


14th Annual Drug Discovery Summit 2013

10 Jun 2013 - 11 Jun 2013 - Geneva, Switzerland



Bookmark and Share


Oxford Global Conferences are proud to present the 14th Annual Drug Discovery Leaders Summit, taking place on 10 & 11 June in Geneva, Switzerland. The summit is made up of two co-located events: Innovation Driven Discovery and Discovery Chemistry & Drug Design.

The drug discovery industry faces a decade of monumental change – stem cell research, generic threat, big data challenges, PHC strategies and the growing focus on biologics all threaten to change the face of the global market. This long-established summit will explore the critical opportunities in drug discovery today, while updating key decision makers on the latest technological breakthroughs.

The Innovation Driven Discovery Congress explores new approaches to screening, assay development and target identification, while experts describe the data integration technologies capable of supporting this innovation. Our esteemed speaker panel will also discuss their strategies for harnessing external innovation and building effective collaborative working methods.

The Discovery Chemistry & Drug Design Congress features presentations on lead optimisation, structure-activity relationships and fragment-based drug discovery. Our internationally renowned speakers will also discuss the latest developments in drug design, including anti-target modelling, advances in polypharmacology and structure based design.

The event will be co-located with our 5th Annual Drug Development Congress; a high-level meeting for those working at the forefront of research, development and translational medicine.



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Identified Compound Stops Cells Making Ribosomes
From study in yeast, researchers have identifed a compound that interferes with the assembly of ribosomes.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!